Farallon Capital Management, L.l.c.

San Francisco, CA 87 processed 13Fs on this site, 2021 Q3 to 2026 Q2

$21.7B
77 holdings
2026 Q2
+23.6% QoQ
Top 5 29.9%

Portfolio

2026 Q2, filed 8/14/2026, top 12 of 77 holdings

Top 5 29.9%, top 10 44.0%

AUM over time

2026 Q2 $21.7B +23.6% QoQ

Q3 2021

Q1 2022

Q1 2023

Q1 2024

Q1 2025

Q1 2026

Book

2023 Q4 2023 Q3, filed 14 Feb, long equity only

Download CSV Download Excel All activity


IQV, IQVIA	3.40%, was 2.73%	Add +7.0%	2,961,032	$231.38	$685M	+194,700	+$141M
EXEL, Exelixis	3.17%, was 2.83%	Add +3.0%	26,634,500	$23.99	$639M	+774,500	+$74M
TMO, Thermo Fisher Scientific	3.17%, was 2.66%	Add +14.9%	1,203,131	$530.79	$639M	+155,600	+$108M
UNH, UnitedHealth Group	3.14%, was 3.40%	Reduce −10.7%	1,202,600	$526.47	$633M	−144,100	−$46M
TRU, Transunion	3.11%, was 3.32%	Reduce −1.2%	9,122,956	$68.71	$627M	−110,300	−$36M
CRM, Salesforce	2.52%, was 2.57%	Reduce −23.8%	1,925,738	$263.14	$507M	−599,900	−$5.4M
MSFT, Microsoft	2.50%	Reduce −0.8%	1,338,578	$376.04	$503M	−10,600	+$77M
WAB, Wabtec	2.48%, was 1.73%	Add +21.0%	3,938,308	$126.90	$500M	+682,261	+$154M
ARMK, Aramark	2.36%, was 2.11%	Add +39.2%	16,899,254	$28.10	$475M	+4,763,054	+$54M
NYT, New York Times	2.30%, was 1.64%	Add +19.0%	9,476,791	$48.99	$464M	+1,512,000	+$136M
GOOG, Alphabet	2.20%, was 2.35%	Reduce −11.8%	3,138,540	$140.93	$442M	−418,600	−$27M
CBRE, CBRE Group	1.96%	Reduce −6.1%	4,246,000	$93.09	$395M	−274,388	+$61M
SPGI, S&P Global	1.93%	Reduce −11.7%	882,595	$440.52	$389M	−116,800	+$24M
NDAQ, Nasdaq	1.90%, was 0.02%	Add +6310.2%	6,570,500	$58.14	$382M	+6,468,000	+$377M
BSX, Boston Scientific	1.67%, was 1.33%	Add +15.5%	5,820,257	$57.81	$336M	+781,000	+$70M
INTU, Intuit	1.65%	Reduce −4.2%	533,000	$625.03	$333M	−23,100	+$49M
CHTR, Charter Communications	1.54%, was 2.45%	Reduce −28.1%	799,141	$388.68	$311M	−312,200	−$178M
CNC, Centene	1.52%, was 1.53%	Reduce −7.0%	4,132,075	$74.21	$307M	−313,000	+$465K
NOW, ServiceNow	1.48%	Reduce −11.8%	421,250	$706.49	$298M	−56,300	+$31M
ADI, Analog Devices	1.47%, was 1.70%	Reduce −23.3%	1,489,100	$198.56	$296M	−452,900	−$44M
CSGP, CoStar Group	1.35%, was 1.07%	Add +12.0%	3,121,356	$87.39	$273M	+334,500	+$58M
YMM, Full Truck Alliance	1.33%	Hold	38,190,495	$7.01	$268M	—	—
MA, Mastercard	1.31%, was 1.20%	Add +2.1%	619,471	$426.51	$264M	+13,000	+$24M
SHW, Sherwin-Williams	1.29%, was 1.34%	Reduce −20.5%	832,092	$311.90	$260M	−214,700	−$7.5M
AZNN	1.28%, was 2.06%	Reduce −36.9%	3,824,291	$67.35	$258M	−2,235,262	−$153M
HWM, Howmet Aerospace	1.27%	Reduce −0.7%	4,716,027	$54.12	$255M	−31,600	+$36M
BX, Blackstone	1.10%, was 1.20%	Reduce −23.8%	1,697,351	$130.92	$222M	−529,700	−$16M
NTRA, Natera	1.08%, was 0.51%	Add +52.5%	3,474,883	$62.64	$218M	+1,197,000	+$117M
V, Visa	1.03%, was 0.88%	Add +4.8%	798,110	$260.35	$208M	+36,700	+$33M
RVMD, Revolution Medicines	0.96%, was 0.46%	Add +102.6%	6,736,854	$28.68	$193M	+3,411,374	+$101M
INSP, Inspire Medical Systems	0.86%, was 0.42%	Add +100.7%	855,096	$203.43	$174M	+429,000	+$89M
Masimo	0.76%, was 0.10%	Add +476.2%	1,311,649	$117.21	$154M	+1,084,000	+$134M
PTGX, Protagonist Therapeutics	0.65%, was 0.46%	Add +5.3%	5,734,430	$22.93	$131M	+288,000	+$41M
Mirati Therapeutics	0.59%, was 0.22%	Add +102.2%	2,024,472	$58.75	$119M	+1,023,472	+$75M
Sarepta Therapeutics	0.58%, was 0.84%	Reduce −12.0%	1,210,073	$96.43	$117M	−165,127	−$50M
VSTS, Vestis	0.57%	New	5,469,753	$21.14	$116M	+5,469,753	+$116M
BEAM, Beam Therapeutics	0.55%	Reduce −8.4%	4,105,753	$27.22	$112M	−376,086	+$4M
UTHR, United Therapeutics	0.52%	New	476,000	$219.89	$105M	+476,000	+$105M
AGIO, Agios Pharmaceuticals	0.46%, was 0.34%	Add +51.5%	4,167,602	$22.27	$93M	+1,416,773	+$25M
CYTK, Cytokinetics	0.45%	Add +4896.2%	1,087,772	$83.49	$91M	+1,066,000	+$90M
ROIV, Roivant Sciences	0.41%, was 0.23%	Add +90.4%	7,336,000	$11.23	$82M	+3,482,600	+$37M
IONS, Ionis Pharmaceuticals	0.39%, was 0.17%	Add +113.9%	1,555,020	$50.59	$79M	+828,020	+$46M
BEKE, KE Holdings	0.38%	Hold	4,758,500	$16.21	$77M	—	—
EVH, Evolent Health	0.35%, was 0.26%	Add +13.8%	2,163,909	$33.03	$71M	+263,000	+$20M
Catalent	0.32%	New	1,413,000	$44.93	$63M	+1,413,000	+$63M
PACB	0.30%, was 0.43%	Reduce −39.4%	6,191,370	$9.81	$61M	−4,032,750	−$25M
HUM, Humana	0.28%, was 0.89%	Reduce −66.7%	121,344	$457.81	$56M	−243,117	−$122M
BABA, Alibaba	0.21%, was 0.37%	Reduce −38.0%	535,000	$77.51	$41M	−327,233	−$33M
PCG, PG&E	0.20%, was 0.34%	Reduce −46.2%	2,271,642	$18.03	$41M	−1,950,000	−$27M
COR, Cencora	0.17%	New	169,000	$205.38	$35M	+169,000	+$35M
BHVN, Biohaven	0.16%	Hold	750,000	$42.80	$32M	—	—
Savara	0.15%, was 0.21%	Reduce −42.7%	6,255,406	$4.70	$29M	−4,652,680	−$12M
THC, Tenet Healthcare	0.14%, was 0.34%	Reduce −63.6%	374,842	$75.57	$28M	−655,158	−$40M
Immunogen	0.12%	New	842,000	$29.65	$25M	+842,000	+$25M
Holding	0.12%	New	567,321	$42.40	$24M	+567,321	+$24M
VRTX, Vertex Pharmaceuticals	0.11%, was 0.35%	Reduce −72.8%	55,000	$406.89	$22M	−147,000	−$48M
OPCH, Option Care Health	0.09%, was 0.14%	Reduce −34.1%	567,800	$33.69	$19M	−294,200	−$8.8M
ENTA, Enanta Pharmaceuticals	0.09%	Add +8.0%	2,025,000	$9.41	$19M	+150,000	−$1.9M
Zymeworks	0.09%	Reduce −12.2%	1,756,000	$10.39	$18M	−244,000	+$5.6M
TAL, Tal Education Group	0.09%	Hold	1,365,000	$12.63	$17M	—	—
SIMO, Silicon Motion Technology	0.07%, was 0.27%	Reduce −76.4%	246,500	$61.27	$15M	−798,500	−$38M
IMVT, Immunovant	0.07%, was 0.10%	Reduce −32.3%	341,000	$42.13	$14M	−163,000	−$5M
LNTH, Lantheus	0.07%, was 0.56%	Reduce −86.7%	213,327	$62.00	$13M	−1,385,173	−$98M
VYGR, Voyager Therapeutics	0.05%	Hold	1,292,000	$8.44	$11M	—	—
Screaming Eagle Acquisitn	0.05%	Hold	1,000,000	$10.60	$11M	—	—
RIO, Rio Tinto	0.05%	Hold	137,500	$74.46	$10M	—	—
TVTX, Travere Therapeutics	0.05%, was 0.01%	Add +302.9%	1,094,000	$8.99	$9.8M	+822,483	+$7.4M
NBIX, Neurocrine Biosciences	0.05%, was 0.25%	Reduce −83.8%	72,398	$131.76	$9.5M	−375,602	−$41M
Holding	0.05%	Hold	1,560,500	$6.03	$9.4M	—	—
Cazoo Group	0.03%	New	714,240	$9.50	$6.8M	+714,240	+$6.8M
SLNO, Soleno Therapeutics	0.03%, was 0.06%	Reduce −57.4%	165,219	$40.25	$6.7M	−222,781	−$4.8M
HCA, HCA Healthcare	0.03%, was 0.22%	Reduce −88.0%	20,900	$270.68	$5.7M	−153,500	−$37M
Gossamer Bio	0.03%	Hold	6,130,272	$0.9125	$5.6M	—	—
Gores Holdings IX	0.03%	Hold	500,000	$10.50	$5.3M	—	—
VNET, Vnet Group	0.03%	Hold	1,775,000	$2.87	$5.1M	—	—
QTRX, Quanterix	0.02%	New	184,000	$27.34	$5M	+184,000	+$5M
IOVA, Iovance Biotherapeutics	0.02%	New	562,000	$8.13	$4.6M	+562,000	+$4.6M
CRNX	0.02%, was 0.05%	Reduce −66.0%	122,904	$35.58	$4.4M	−239,000	−$6.4M
Swiftmerge Acquisition	0.02%	Hold	300,000	$10.76	$3.2M	—	—
Berenson Acquisition	0.01%	Hold	285,715	$10.25	$2.9M	—	—
Bluebird Bio	0.01%	New	2,000,000	$1.38	$2.8M	+2,000,000	+$2.8M
Arya Sciences Acqu Corporation IV	0.01%	Hold	200,000	$10.88	$2.2M	—	—
Metals Acquisition	0.01%	New	157,500	$12.36	$1.9M	+157,500	+$1.9M
Marblegate Acquisition	0.01%	Hold	150,000	$10.43	$1.6M	—	—
Forte Biosciences	0.01%	Hold	1,810,455	$0.8217	$1.5M	—	—
Cara Therapeutics	0.01%	Reduce −6.6%	1,556,251	$0.7430	$1.2M	−110,340	−$1.6M
Summit Midstream Partners	0.01%	Hold	58,214	$17.91	$1M	—	—
EDU	0.00%	Hold	13,000	$73.28	$953K	—	—
Sage Therapeutics	0.00%	Hold	42,800	$21.67	$927K	—	—
MDGL, Madrigal Pharmaceuticals	0.00%	Hold	3,319	$231.38	$768K	—	—
CRL, Charles River Labs International	0.00%, was 0.14%	Reduce −98.6%	2,000	$236.40	$473K	−144,000	−$28M
BNTX, Biontech	0.00%	Hold	3,844	$105.54	$406K	—	—
ALNY, Alnylam Pharmaceuticals	0.00%	Hold	2,000	$191.41	$383K	—	—
HIMS, Hims & Hers Health	0.00%	Hold	42,000	$8.90	$374K	—	—
Blueprint Medicines	0.00%	Hold	4,000	$92.24	$369K	—	—
APLS, Apellis Pharmaceuticals	0.00%, was 0.04%	Reduce −96.9%	6,000	$59.86	$359K	−188,053	−$7M
AXSM, Axsome Therapeutics	0.00%, was 0.04%	Reduce −96.8%	4,000	$79.59	$318K	−121,653	−$8.5M
KRYS, Krystal Biotech	0.00%	Hold	2,000	$124.06	$248K	—	—
CHE, Chemed	0.00%	Hold	400	$584.75	$234K	—	—
FOLD, Amicus	0.00%	Hold	16,000	$14.19	$227K	—	—
EHC, Encompass Health	0.00%	Hold	3,000	$66.72	$200K	—	—
R1 RCM	0.00%	Add +33.3%	16,000	$10.57	$169K	+4,000	−$12K
COGT, Cogent Biosciences	0.00%	Hold	17,000	$5.88	$100K	—	—

Showing top 50 of 103 by value

Exits / last held

Gone since 2023 Q3, shown at their last reported size.

Stock	% of portfolio	Recent activity	Reported price*	Value	Share change	$ change
Activision Blizzard	9.54%	Exit	$93.63	$1.9B	−20,320,000	−$1.9B
Horizon Therapeutics Pub	3.86%	Exit	$115.69	$770M	−6,656,823	−$770M
AON, Aon	1.08%	Exit	$324.22	$216M	−665,661	−$216M
ELV, Elevance Health	0.83%	Exit	$435.42	$166M	−381,330	−$166M
CI, Cigna	0.52%	Exit	$286.07	$105M	−366,000	−$105M
XYZ, Block	0.52%	Exit	$44.26	$103M	−2,336,350	−$103M
DXCM, DexCom	0.25%	Exit	$93.30	$51M	−544,000	−$51M
Denbury	0.21%	Exit	$98.01	$42M	−425,000	−$42M
United States Steel	0.10%	Exit	$32.48	$21M	−635,000	−$21M
Sdcl Edge Acquisition	0.09%	Exit	$10.60	$18M	−1,732,500	−$18M
National Instruments	0.08%	Exit	$59.62	$16M	−265,000	−$16M
Ares Acquisition	0.08%	Exit	$10.76	$15M	−1,425,000	−$15M
Earthstone Energy	0.06%	Exit	$20.24	$13M	−618,831	−$13M
Chindata Group	0.05%	Exit	$8.30	$11M	−1,300,000	−$11M
Slam	0.03%	Exit	$10.78	$6.1M	−570,396	−$6.1M
Holding	0.02%	Exit	$10.38	$4.2M	−400,000	−$4.2M
Verve Therapeutics	0.01%	Exit	$13.26	$2.8M	−211,293	−$2.8M
OKLO, Altc Acquisition	0.01%	Exit	$10.35	$1M	−98,300	−$1M
Lufax	—	Exit	$1.06	$636K	−600,000	−$636K
Karuna Therapeutics	—	Exit	$169.09	$372K	−2,200	−$372K
HQY, Healthequity	—	Exit	$73.21	$205K	−2,800	−$205K
Akero Therapeutics	—	Exit	$50.50	$202K	−4,000	−$202K

Filings history

20 periods, with AUM normalized

Newest 13Fs

Period	Holds	AUM	QoQ	Form	Filed	Filing ID
2026 Q2	89	$21.7B	+23.6%	13F-HR	8/14/2026	000090883426000432
2026 Q1	1	$1.5B	—	new holds	8/14/2026	000090883426000434
2026 Q1	172	$17.5B	−17.2%	13F-HR	5/15/2026	000090883426000240
2025 Q4	1	$1B	—	new holds	8/14/2026	000090883426000433
2025 Q4	2	$884M	—	new holds	5/15/2026	000090883426000241
2025 Q4	151	$21.2B	−13.2%	13F-HR	2/17/2026	000090883426000087
2025 Q3	144	$24.4B	—	RESTATEMENT	2/17/2026	000090883426000086
2025 Q3	144	$24.4B	+5.4%	13F-HR	11/14/2025	000090883425000353
2025 Q2	1	$140M	—	new holds	2/17/2026	000090883426000085
2025 Q2	3	$483M	—	new holds	11/14/2025	000090883425000352
2025 Q2	141	$23.2B	+29.2%	13F-HR	8/14/2025	000090883425000248
2025 Q1	1	$274M	—	new holds	2/17/2026	000090883426000084
2025 Q1	3	$416M	—	new holds	11/14/2025	000090883425000351
2025 Q1	7	$2.2B	—	new holds	8/14/2025	000090883425000247
2025 Q1	135	$17.9B	−9.0%	13F-HR	5/15/2025	000090883425000177
2024 Q4	1	$85M	—	new holds	2/17/2026	000090883426000083
2024 Q4	2	$349M	—	new holds	11/14/2025	000090883425000350
2024 Q4	6	$2.3B	—	new holds	8/14/2025	000090883425000246
2024 Q4	4	$333M	—	new holds	5/15/2025	000090883425000180
2024 Q4	138	$19.7B	−3.5%	13F-HR	2/14/2025	000090883425000081
2024 Q3	1	$145M	—	new holds	11/14/2025	000090883425000349
2024 Q3	6	$1.5B	—	new holds	8/14/2025	000090883425000243
2024 Q3	3	$216M	—	new holds	5/15/2025	000090883425000179
2024 Q3	2	$544M	—	new holds	2/14/2025	000090883425000080
2024 Q3	153	$20.4B	−3.6%	13F-HR	11/14/2024	000090883424000307
2024 Q2	1	$120M	—	new holds	11/14/2025	000090883425000348
2024 Q2	5	$1.2B	—	new holds	8/14/2025	000090883425000245
2024 Q2	1	$199M	—	new holds	5/15/2025	000090883425000178
2024 Q2	2	$452M	—	new holds	2/14/2025	000090883425000079
2024 Q2	1	$149M	—	new holds	11/14/2024	000090883424000324
2024 Q2	157	$21.2B	−4.2%	13F-HR	8/14/2024	000090883424000200
2024 Q1	1	$93M	—	new holds	11/14/2025	000090883425000347
2024 Q1	4	$1.2B	—	new holds	8/14/2025	000090883425000244
2024 Q1	2	$159M	—	new holds	2/14/2025	000090883425000078
2024 Q1	1	$45M	—	new holds	8/14/2024	000090883424000202
2024 Q1	167	$22.1B	—	RESTATEMENT	5/24/2024	000090883424000159
2024 Q1	167	$22.1B	+9.8%	13F-HR	5/15/2024	000090883424000135
2023 Q4	1	$65M	—	new holds	11/14/2025	000090883425000346
2023 Q4	2	$548M	—	new holds	8/14/2025	000090883425000250
2023 Q4	5	$1.1B	—	new holds	5/15/2024	000090883424000141
2023 Q4	150	$20.1B	+1.0%	13F-HR	2/14/2024	000090883424000070
2023 Q3	1	$40M	—	new holds	11/14/2025	000090883425000345
2023 Q3	1	$40M	—	new holds	5/15/2024	000090883424000138
2023 Q3	2	$1.4B	—	new holds	2/14/2024	000090883424000077
2023 Q3	1	$1.9B	—	new holds	2/12/2024	000090883424000049
2023 Q3	159	$20B	+11.5%	13F-HR	11/14/2023	000090883423000150
2023 Q2	2	$669M	—	new holds	2/14/2024	000090883424000076
2023 Q2	5	$1.4B	—	new holds	11/14/2023	000090883423000157
2023 Q2	1	$1.2B	—	new holds	10/26/2023	000090883423000134
2023 Q2	165	$17.9B	+1.3%	13F-HR	8/14/2023	000090883423000109
2023 Q1	2	$234M	—	new holds	2/14/2024	000090883424000075
2023 Q1	3	$389M	—	new holds	11/14/2023	000090883423000156
2023 Q1	1	$15M	—	new holds	8/14/2023	000090883423000110
2023 Q1	187	$17.7B	+15.8%	13F-HR	5/15/2023	000117570723000127
2022 Q4	1	$171M	—	new holds	2/14/2024	000090883424000074
2022 Q4	3	$485M	—	new holds	11/14/2023	000090883423000155
2022 Q4	7	$1B	—	new holds	5/15/2023	000117570723000136
2022 Q4	232	$15.3B	−9.3%	13F-HR	2/14/2023	000117570723000051
2022 Q3	1	$125M	—	new holds	2/14/2024	000090883424000073
2022 Q3	3	$415M	—	new holds	11/14/2023	000090883423000154
2022 Q3	5	$411M	—	new holds	5/15/2023	000117570723000135
2022 Q3	4	$434M	—	new holds	2/14/2023	000090966123000005
2022 Q3	298	$16.8B	+3.5%	13F-HR	11/14/2022	000156761922019851
2022 Q2	1	$115M	—	new holds	2/14/2024	000090883424000081
2022 Q2	3	$411M	—	new holds	11/14/2023	000090883423000153
2022 Q2	2	$337M	—	new holds	5/15/2023	000117570723000134
2022 Q2	3	$136M	—	new holds	2/14/2023	000090966123000003
2022 Q2	9	$1.2B	—	new holds	11/14/2022	000156761922019862
2022 Q2	297	$16.3B	−13.7%	13F-HR	8/15/2022	000156761922015953
2022 Q1	1	$268M	—	new holds	11/14/2023	000090883423000152
2022 Q1	1	$314M	—	new holds	5/15/2023	000117570723000133
2022 Q1	1	$27M	—	new holds	2/14/2023	000090966123000002
2022 Q1	3	$186M	—	new holds	11/14/2022	000156761922019864
2022 Q1	8	$1.1B	—	new holds	8/15/2022	000156761922015972
2022 Q1	307	$18.8B	+0.4%	13F-HR	5/16/2022	000156761922010736
2021 Q4	1	$227M	—	new holds	5/15/2023	000117570723000132
2021 Q4	1	$7M	—	new holds	11/14/2022	000156761922019852
2021 Q4	1	$115M	—	new holds	8/15/2022	000156761922015968
2021 Q4	2	$98M	—	new holds	5/19/2022	000156761922011257
2021 Q4	6	$833M	—	new holds	5/16/2022	000156761922010757
2021 Q4	289	$18.7B	−5.1%	13F-HR	2/14/2022	000156761922003965
2021 Q3	1	$182M	—	new holds	5/15/2023	000117570723000131
2021 Q3	1	$105M	—	new holds	8/15/2022	000156761922015964
2021 Q3	1	$57M	—	new holds	5/19/2022	000156761922011256
2021 Q3	3	$998M	—	new holds	5/16/2022	000156761922010753
2021 Q3	2	$344M	—	new holds	2/14/2022	000156761922003981
2021 Q3	293	$19.7B	—	13F-HR	11/15/2021	000095012321015168

About

Farallon Capital Management, L.l.c.

87 processed 13Fs on this site, 2021 Q3 to 2026 Q2

SEC filing name: FARALLON CAPITAL MANAGEMENT, L.L.C.
Location: San Francisco, CA
All SEC filings: View on sec.gov